(Asn670,Leu671)-Amyloid b/A4 Protein Precursor770 (667-676) 1mg

(Asn670,Leu671)-Amyloid b/A4 Protein Precursor770 (667-676) 1mg
Product Description

Chinese peptide co provides wide range of products which includes (asn670,leu671)-amyloid b/a4 protein precursor770 (667-676) 1mg. It belongs to?-amyloids and related peptides category. Contact us for more information.

CPC Scientific.Inc

  • US
  • 2015
    On CPHI since
  • 500 - 999
    Employees
Company types
CMO/CDMO
Contract Service
Specifications
  • Details
    Formula: C50H78N14O19
  • Selling Points
    Brand Name; Experienced Technicians
  • Supplied from
    China

CPC Scientific.Inc

  • US
  • 2015
    On CPHI since
  • 500 - 999
    Employees
Company types
CMO/CDMO
Contract Service

More Products from CPC Scientific.Inc (99)

  • AMYD-014A

    Product AMYD-014A

    Cpc provides wide range of products which includes amyd-014a. Category: ß-amyloids and related peptides. Contact us for more information.
  • AMYD-015A

    Product AMYD-015A

    Cpc provides wide range of products which includes amyd-015a. Category: ß-amyloids and related peptides. Contact us for more information.
  • AMYD-016A

    Product AMYD-016A

    Cpc provides wide range of products which includes amyd-016a. Category: ß-amyloids and related peptides. Contact us for more information.
  • AMYD-017A

    Product AMYD-017A

    Cpc provides wide range of products which includes amyd-017a. Category: ß-amyloids and related peptides. Contact us for more information.
  • AMYD-018A

    Product AMYD-018A

    Cpc provides wide range of products which includes amyd-018a. Category: ß-amyloids and related peptides. Contact us for more information.
  • Tirzepatide
  • (Cys(Bzl)84,Glu(OBzl)85)-CD4 (81-92) 25mg

    Product (Cys(Bzl)84,Glu(OBzl)85)-CD4 (81-92) 25mg

    Chinese peptide co provides wide range of products which includes (cys(bzl)84,glu(obzl)85)-cd4 (81-92) 25mg. It belongs tohiv related peptide category. Contact us for more information.
  • (Cys(Bzl)84,Glu(OBzl)85)-CD4 (81-92) 5mg

    Product (Cys(Bzl)84,Glu(OBzl)85)-CD4 (81-92) 5mg

    Chinese peptide co provides wide range of products which includes (cys(bzl)84,glu(obzl)85)-cd4 (81-92) 5mg. It belongs tohiv related peptide category. Contact us for more information.
  • (Cys39)-Tissue Factor (33-53) 0.5mg

    Product (Cys39)-Tissue Factor (33-53) 0.5mg

    Chinese peptide co provides wide range of products which includes (cys39)-tissue factor (33-53) 0.5mg. It belongs toanticoagulant and antithrombotic peptides category. Contact us for more information.
  • (Cys39)-Tissue Factor (33-53) 1mg

    Product (Cys39)-Tissue Factor (33-53) 1mg

    Chinese peptide co provides wide range of products which includes (cys39)-tissue factor (33-53) 1mg. It belongs toanticoagulant and antithrombotic peptides category. Contact us for more information.
  • (Deamino-Cys1,D-Tyr(Et)2,Thr4,Orn8)-Oxytocin;Atosiban 250mg

    Product (Deamino-Cys1,D-Tyr(Et)2,Thr4,Orn8)-Oxytocin;Atosiban 250mg

    Chinese peptide co provides wide range of products which includes (deamino-cys1,d-tyr(et)2,thr4,orn8)-oxytocin;atosiban 250mg. It belongs tooxytocin, vasotocin and analogs category. Contact us for more information.
  • (Deamino-Cys1,D-Tyr(Et)2,Thr4,Orn8)-Oxytocin;Atosiban 50mg

    Product (Deamino-Cys1,D-Tyr(Et)2,Thr4,Orn8)-Oxytocin;Atosiban 50mg

    Chinese peptide co provides wide range of products which includes (deamino-cys1,d-tyr(et)2,thr4,orn8)-oxytocin;atosiban 50mg. It belongs tooxytocin, vasotocin and analogs category. Contact us for more information.

CPC Scientific.Inc resources (1)

  • News Terlipressin Formulation with API Manufactured by CPC Scientific Approved for Further Study by the MEB

    SAN JOSE, CA., Feb 1, 2021 /CPCNewswire/ — CPC Scientific Inc. is pleased to announce that the Dutch Medicines Evaluation Board (MEB) has completed its technical review of their client’s drug product and formulation process for Terlipressin. The API provided to the client is manufactured at CPC Scientific’s GMP facility. On January 18, 2021, the MEB granted approval of the drug product and will move to the next phase to review product characterization profiles, specifications, and labels in the Netherlands. The MEB is the Dutch regulatory agency responsible for assessing, monitoring, and promoting the proper use of medicines. After final approval, the drug product will be available for sale in the Netherlands and Germany.